SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ONCO, WAT, XAGE on Behalf of Shareholders
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 18 2025
0mins
Source: PRnewswire
Investigation of Mergers: Halper Sadeh LLC is investigating potential violations of federal securities laws related to mergers involving Onconetix, Waters Corporation, and Longevity Health Holdings, focusing on shareholder rights and options.
Legal Support for Shareholders: The law firm offers free consultations to shareholders affected by these mergers, aiming to seek increased consideration and corporate reforms on a contingent fee basis.
Analyst Views on ONCO
About ONCO
Onconetix, Inc. is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men’s health and oncology. The Company owns Proclarix, an in vitro diagnostic test for prostate cancer approved for sale in the European Union under the In Vitro Diagnostic Regulation. Proclarix is an easy-to-use next generation protein-based blood test that can be done with the same sample as a patient’s regular Prostate-Specific Antigen (PSA) test.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
